EUVIMEDEUVIMED entdecken
Crossref

Outcomes Following Total Hip Arthroplasty in Patients Who Have Von Willebrand Disease Depend on Postoperative Anticoagulation

Will M Jiang, Joshua G Sanchez, Meera M Dhodapkar, Zachary J Radford, Lee E Rubin, Jonathan N Grauer

The Journal of Arthroplasty · 2024

DOI: 10.1016/j.arth.2024.03.004 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2024. Verfasst von Will M Jiang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Yale Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, New Haven, Connecticut. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Anticoagulants, Venous Thromboembolism, von Willebrand Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Johns Hopkins University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Von Willebrand disease (VWD) is the most common congenital bleeding disorder. This autosomal dominant condition arises from quantitative or qualitative defects of Von Willebrand factor. To our knowledge, this study leveraged a national database to characterize the largest VWD cohort of total hip arthroplasty (THA) patients to date, assessing 90-day postoperative adverse events and 5-year revision-free survival. METHODS: Adult patients who underwent primary THA for osteoarthritis were identified from January 2010 to October 2021 in a nationwide database. Patients who had and did not have VWD were matched (4:1) on age, sex, and Elixhauser Comorbidity Index and compared with multivariable logistic regression. Patients were then categorized based upon venous thromboembolism (VTE) chemoprophylaxis prescription patterns to compare bleeding and thrombotic adverse events. RESULTS: Of 544,851 THA patients, VWD was identified in 309 patients (0.06%). The matched cohorts contained 1,221 patients who did not have VWD and 306 patients who have VWD. On multivariable analysis, VWD patients had increased odds of 90-day VTE (odds ratio [OR] = 1.86) and hematoma (OR = 3.40) (P < .05 for all). No difference in 5-year revision-free survival was found. The VWD patients receiving aspirin or no prescriptions had greater odds of VTE (OR = 2.39, P = .048). Those on other chemoprophylaxis agents had greater odds of hematoma (OR = 4.84, P = .006). CONCLUSIONS: Patients with VWD undergoing THA had increased odds of 90-day VTE if using aspirin or no prescriptions, or hematoma if using other chemoprophylaxis. There is a delicate balancing act of clotting versus bleeding that must be considered in managing such patients, but it was reassuring that no difference in overall 5-year revision-free survival was found.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthroplasty, Replacement, HipAnticoagulantsVenous Thromboembolismvon Willebrand DiseasesHumansFemaleMaleMiddle AgedAgedOsteoarthritis, HipPostoperative ComplicationsTreatment OutcomeAdultRetrospective StudiesHematoma

Stichwörter der Autor:innen

anticoagulationbleeding riskpostoperative complicationstotal hip arthroplastyvenous thromboembolismvon Willebrand disease

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Yale Department of Orthopaedics and Rehabilitation, Yale University School of Medicine, New Haven, Connecticut.

Förderung

  • Johns Hopkins University

Zitieren

APA

Jiang, W. M., Sanchez, J. G., Dhodapkar, M. M., Radford, Z. J., Rubin, L. E., & Grauer, J. N. (2024). Outcomes Following Total Hip Arthroplasty in Patients Who Have Von Willebrand Disease Depend on Postoperative Anticoagulation. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2024.03.004

Vancouver

Jiang WM, Sanchez JG, Dhodapkar MM, Radford ZJ, Rubin LE, Grauer JN. Outcomes Following Total Hip Arthroplasty in Patients Who Have Von Willebrand Disease Depend on Postoperative Anticoagulation. The Journal of Arthroplasty. 2024. doi:10.1016/j.arth.2024.03.004

BibTeX
@article{Jiang2024,
  author = {Jiang, Will M and Sanchez, Joshua G and Dhodapkar, Meera M and Radford, Zachary J and Rubin, Lee E and Grauer, Jonathan N},
  title = {Outcomes Following Total Hip Arthroplasty in Patients Who Have Von Willebrand Disease Depend on Postoperative Anticoagulation},
  journal = {The Journal of Arthroplasty},
  year = {2024},
  doi = {10.1016/j.arth.2024.03.004}
}
Kostenlos starten →